Brian K. Beeler's most recent trade in Horizon Therapeutics Plc was a trade of 28,143 Ordinary Shares done at an average price of $107.9 . Disclosure was reported to the exchange on Sept. 17, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 107.91 per share. | 17 Sep 2021 | 28,143 | 62,775 (0%) | 0% | 107.9 | 3,036,911 | Ordinary Shares |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 106.00 per share. | 16 Aug 2021 | 74,898 | 90,918 (0%) | 0% | 106 | 7,939,188 | Ordinary Shares |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.14 per share. | 16 Aug 2021 | 65,857 | 165,816 (0%) | 0% | 22.1 | 1,458,074 | Ordinary Shares |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 65,857 | 0 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 11,612 | 11,612 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2021 | 5,806 | 102,532 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.50 per share. | 28 Jul 2021 | 2,573 | 99,959 (0%) | 0% | 102.5 | 263,733 | Ordinary Shares |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 90.12 per share. | 31 Mar 2021 | 26,844 | 95,677 (0%) | 0% | 90.1 | 2,419,181 | Ordinary Shares |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 11,610 | 11,610 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 3,144 | 3,144 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 1,571 | 123,217 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.17 per share. | 17 Feb 2021 | 696 | 122,521 (0%) | 0% | 87.2 | 60,670 | Ordinary Shares |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 4,120 | 4,120 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 4,120 | 123,472 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.43 per share. | 21 Jan 2021 | 1,826 | 121,646 (0%) | 0% | 77.4 | 141,387 | Ordinary Shares |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 60,313 | 163,537 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.28 per share. | 04 Jan 2021 | 44,185 | 119,352 (0%) | 0% | 73.3 | 3,237,877 | Ordinary Shares |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 39,196 | 103,224 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 24,449 | 24,449 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 17,260 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 12,261 | 12,261 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Brian K. Beeler | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 9,675 | 19,352 | - | - | Restricted Stock Units (RSU) |